TENAX THERAPEUTICS,

TENX
Delayed Quote. Delayed  - 05/13 04:00:00 pm
2.01USD -4.29%

Turn to zoom
Prev.2.1000
Open2.0700
High2.1000
Low1.9500
Volume115 373
Latest news
04/27
04/21
04/20
04/09
Chart TENAX THERAPEUTICS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance2,242,792,70
Spread/Res.-10%-28%-26%
Spread/Supp.1,5%18%26%
Support1,981,711,60
Financials
Sales 2021 - - -
Net income 2021 -12,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,32x
Yield 2021 -
Capitalization 30,1 M 30,1 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 1,20x
Nbr of Employees -
Free-Float 92,2%
Company
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-06-10 Shareholder meeting

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 4,75 $
Last Close Price 2,01 $
Spread / Highest target 149%
Spread / Average Target 136%
Spread / Lowest Target 124%